Normal view MARC view ISBD view

NIH conference. Future directions in the study and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. [electronic resource]

By:

Merke, Deborah P

Contributor(s):

Producer: 20020426Description: 320-34 p. digitalISSN:

1539-3704

Subject(s):

Online resources:

Available from publisher's website

In: Annals of internal medicine vol. 136

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Consensus Development Conference; Consensus Development Conference, NIH; Journal Article; Review

There are no comments on this title.

to post a comment.

Previous

Back to results

Next

1
2
3
4
5
6
7
8
9
10

1 Disruption of G protein-coupled receptor 39 impairs insulin secretion in vivo.
by Tremblay, Frédéric
2 Superior reductions in hepatic steatosis and fibrosis with co-administration of a glucagon-like peptide-1 receptor agonist and obeticholic acid in mice.
by Jouihan, Hani
3 Gut check on diabesity: leveraging gut mechanisms for the treatment of type 2 diabetes and obesity.
by Will, Sarah
4 A GLP-1:CCK fusion peptide harnesses the synergistic effects on metabolism of CCK-1 and GLP-1 receptor agonism in mice.
by Hornigold, David C
5 Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction.
by Boland, Michelle L
6 Molecular activation of PPARgamma by angiotensin II type 1-receptor antagonists.
by Erbe, David V
7 Loss of coiled-coil domain containing 80 negatively modulates glucose homeostasis in diet-induced obese mice.
by Tremblay, Frédéric
8 Combined loss of GLP-1R and Y2R does not alter progression of high-fat diet-induced obesity or response to RYGB surgery in mice.
by Boland, Brandon B
9 Activation of TrkB with TAM-163 results in opposite effects on body weight in rodents and non-human primates.
by Perreault, Mylène
10 Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent.
by Artis, Dean R

Close